- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: SCOTUS Asks for More Information in Contraception Case
What we're reading, March 30, 2016: the Supreme Court asks for more information in birth control case; Americans display lack of knowledge about Zika virus; and China provides an opportunity for drugs that fail to make it to market elsewhere.
With only 8 sitting members on the Supreme Court, the judges appear deadlocked on an important case on contraception access. Kaiser Health News reported that the court has asked lawyers involved in the case to provide more information on how women working for religious employers may access birth control. The judges had seemed evenly divided after arguments last week, and the court is also asking the lawyers to provide a possible compromise in the case.
Although Americans recognize that the Zika virus is spreading and could reach the continental US, they are unaware of the basic facts of the virus. While a large majority of people realize the virus is spread by mosquitoes, one-third also believe Zika can be spread by coughing or sneezing, according to USA Today. In addition, nearly one-fourth of adults in households where someone is pregnant or considering becoming pregnant didn’t know about the link between Zika and microcephaly.
China is providing a second life for some drugs that don’t make it to market elsewhere in the world. Companies licensing drugs to Chinese startups after a treatment fails to outperform other drugs is becoming a new trend, reported The Wall Street Journal. However, it isn’t unusual or unlawful for companies to get a drug approved in one jurisdiction but not another, and in China companies don’t have to prove a drug’s superiority over existing treatments.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
